PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Achim Rody Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

02/2006	C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
03/2005	Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor.
10/2004	Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast.

Articles by Research Topic

Disease

5	Breast Neoplasms (Breast Cancer) 01/2007 - 07/2003
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2006 - 10/2004
1	Neoplasms (Cancer) 02/2007

Drug/Important Bio-Agent (IBA)

2	Estrogen Receptor alphaIBA 03/2005 - 10/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2005 - 10/2004
1	Estrogens (Estrogen)FDA Link 02/2007
1	plexinIBA 02/2007
1	Aromatase (CYP19)IBA 06/2006
1	Tamoxifen FDA LinkGeneric 06/2006
1	letrozole (Femara)FDA Link 06/2006
1	Carbon MonoxideIBA 02/2006
1	Goserelin (Zoladex)FDA Link 08/2005
1	Androgen Receptors (Androgen Receptor)IBA 03/2005
1	Endothelin B ReceptorIBA 09/2003
1	Endothelin-1 (Endothelin 1)IBA 09/2003
1	Endothelins (Endothelin)IBA 09/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2007